A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab
Condition: Angioplasty, Transluminal, Percutaneous CoronaryInterventions: Other: Angioplasty; Other: Intracoronary Stent; Drug: Abxicimab; Drug: Heparin; Drug: PlaceboSponsor: Centocor, Inc.Completed - verified May 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials